Evidence map›Paper›PMID 30880078›Full record

ArticleStem cell reports2019

WDR5, BRCA1, and BARD1 Co-regulate the DNA Damage Response and Modulate the Mesenchymal-to-Epithelial Transition during Early Reprogramming.

Georgina Peñalosa-Ruiz, Vicky Bousgouni, Jan P Gerlach, Susan Waarlo, Joris V van de Ven, Tim E Veenstra, José C R Silva, Simon J van Heeringen, Chris Bakal, Klaas W Mulder and 1 more

Abstract read
In one paragraph

Article in Stem cell reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. The complex activities of the SET1/MLL complex core subunits in development and disease.Biochimica et biophysica acta. Gene regulatory mechanisms · 2020
    Review
  9. Article
  10. Tox4 modulates cell fate reprogramming.Journal of cell science · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Georgina Peñalosa-RuizDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands.
Vicky BousgouniDynamical Cell Systems Team, Division of Cancer Biology, Chester Beatty Laboratories Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
Jan P GerlachDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands.
Susan WaarloDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands.
Joris V van de VenDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands.
Tim E VeenstraDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands.
José C R SilvaWelcome Trust Medical Research Council Cambridge Stem Cell Institute and Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK.
Simon J van HeeringenDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands.
Chris BakalDynamical Cell Systems Team, Division of Cancer Biology, Chester Beatty Laboratories Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.
Klaas W MulderDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands. Electronic address: k.mulder@science.ru.nl.
Gert Jan C VeenstraDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6500 HB, the Netherlands. Electronic address: g.veenstra@science.ru.nl.

Funding

Cancer Research UK 20146Cancer Research UK C37275/1A20146Medical Research Council MC_PC_12009
6 · The paper itself

Abstract

Differentiated cells are epigenetically stable, but can be reprogrammed to pluripotency by expression of the OSKM transcription factors. Despite significant effort, relatively little is known about the cellular requirements for reprogramming and how they affect the properties of induced pluripotent stem cells. We have performed high-content screening with small interfering RNAs targeting 300 chromatin-associated factors and extracted colony-level quantitative features. This revealed five morphological phenotypes in early reprogramming, including one displaying large round colonies exhibiting an early block of reprogramming. Using RNA sequencing, we identified transcriptional changes associated with these phenotypes. Furthermore, double knockdown epistasis experiments revealed that BRCA1, BARD1, and WDR5 functionally interact and are required for the DNA damage response. In addition, the mesenchymal-to-epithelial transition is affected in Brca1, Bard1, and Wdr5 knockdowns. Our data provide a resource of chromatin-associated factors in early reprogramming and underline colony morphology as an important high-dimensional readout for reprogramming quality.

Indexed as

DNA DamageAnimalsBRCA1 ProteinCellular ReprogrammingChromatinDNA RepairEpithelial-Mesenchymal TransitionGene Expression ProfilingHumansIntracellular Signaling Peptides and ProteinsMicePhenotypeSignal TransductionTranscription FactorsTumor Suppressor ProteinsUbiquitin-Protein LigasesBARD1 protein, humanBRCA1 ProteinBRCA1 protein, humanChromatinIntracellular Signaling Peptides and ProteinsTranscription FactorsTumor Suppressor ProteinsUbiquitin-Protein LigasesWDR5 protein, humanBARD1BRCA1chromatin factorsDNA damage repairfunctional interactionsiPSCsmesenchymal-to-epithelial transitionreprogrammingWDR5

Identifiers

PMID30880078
PMCPMC6449870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.